This international, non-promotional website created by developed and funded by Pierre Fabre is intended only for HealthCare Professionals outside the United States for educational purposes. This tool is designed solely for educational purposes to help healthcare professionals visualise and understand the results of the statistical modelling study published by Gravas S. et al, 2024. It has not been validated for and is not intended for clinical use with individual patients. It is not intended to substitute for medical assessment or to drive or inform diagnostic or therapeutic decisions for any conditions for individual patients.

The Irani score has been established as a measurement scale to categorize inflammation based on precise morphological criteria.1 The Irani inflammation score is a method that provides valuable insights into the inflammatory state of the prostate.2 By establishing a relationship between the morphological characteristics of inflammation and PSA levels, this score enriches the clinical analysis of BPH and may influence the global management of patients.1 The Irani is the standard for classifying all categories of inflammation.2

Inflammation and aggressiveness scales1

The scoring system is divided into two distinct scales: the inflammation scale and the aggressiveness scale.

Clinical significance of scores2

Scores from 0 to 2 Clinical Significance of Scores are generally interpreted as minimal to moderate inflammation, while scores from 3 to 6 indicate moderate to severe inflammation. The nomogram determines the probability of an Irani score between 3 and 6.

The Irani score is particularly useful in classifying categories of prostatic inflammation. It standardizes the assessment of inflammation, which can aid in the interpretation of prostate biopsies and in clinical decision-making.

1. Irani J, et al. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol. 1997 Apr;157(4):1301-3. doi: 10.1016/s0022-5347(01)64957-7. PMID: 9120926.

2. Gravas S, et al. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms. Prostate Cancer Prostatic Dis. 2024 Jul 6. doi: 10.1038/s41391-024-00857-5. Epub ahead of print. PMID: 38971935